Karnofsky Performance Status Scale (KPS Scale)

Save this PDF as:
 WORD  PNG  TXT  JPG

Size: px
Start display at page:

Download "Karnofsky Performance Status Scale (KPS Scale)"

Transcription

1 Karnofsky Performance Status Scale (KPS Scale) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by CDISC and Analgesic Clinical Trial Translations, Innovations, Opportunities, and Networks (ACTTION) Notes to Readers This implementation guide is intended to be used with other CDISC User Guides for specific Therapeutic/Disease Areas and follows the CDISC Study Data Tabulation Model Implementation Guide for Human Clinical trials. Revision History Date Version Summary of Changes Karnofsky performance status scale (KPSS) Draft Karnofsky performance status scale (KPSS)

2 1 Introduction This document describes the CDISC implementation of the Karnofsky Performance Status Scale (KPS Scale) questionnaire, a standard questionnaire administered on a CRF that is typically used in clinical trials to measure pain response. The KPS Scale CRF preceded the CDISC CDASH CRF standards and based on its copyright status, cannot be modified to CDASH standards. The representation of data collected for this questionnaire is based on the Study Data Tabulation Model Implementation Guide (SDTMIG) QS domain table, which can be found at the CDISC website at: ( These specific implementation details for this specific questionnaire are meant to be used in conjunction with the SDTMIG, but are recorded separately since this questionnaire may be used in many different therapeutic area implementations. All questionnaire documentation can be found on the CDISC web site at: ( The CDISC Intellectual Property Policy can be found on the CDISC web site at: ( 1.1 Representations and Warranties, Limitations of Liability, and Disclaimers This document is a supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials and is covered under Appendix F of that document, which describes representations, warranties, limitations of liability, and disclaimers. Please see Appendix F of the SDTMIG for a complete version of this material. 2 Copyright Status This instrument is in the public domain. CDISC has included the Karnofsky Performance Status Scale (KPS Scale) as part of CDISC Data Standards. This means that CDISC developed QSTESTCD and QSTEST for each question based on the actual question text on the questionnaire. There may be many versions of this questionnaire in the public domain. CDISC has chosen to use this version as the data standard. The CDISC documentation of this instrument consists of: (1) controlled terminology, (2) standard database structure with examples and (3) case report forms annotated with the CDISC SDTMIG submission values. CDISC has developed this documentation at no cost to users of the instrument Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 2

3 3 The QS Domain Model 3.1 Assumptions for Questionnaire Domain Model All assumptions for the QS domain from the SDTMIG apply for this supplemental implementation guide including those referenced in the CDISC notes. Additionally, the following assumption applies to the KARNOFSKY PERFORMANCE STATUS SCALE: 1. Karnofsky Performance Status Scale (KPSS): KPSS allows patients to be classified as to their functional impairment. This can be used to compare effectiveness of different therapies and to assess the prognosis in individual patients. The lower the Karnofsky score, the worse the survival for most serious illnesses. 2. Visual analog or numeric rating scales used within a questionnaire with a range of text and numeric values are indicated in the SUPPQS domain with: QNAM=RNGTXTLO QNAM=RNGTXTHI QNAM=RNGVALLO QNAM=RNGVALHI By storing this information in SUPPQS, it is available for interpretation purposes. The SDS QS Team is researching alternative methods to handle this data, but until a new method is identified, this will be the agreed approach. 3. The evaluator of the questionnaire is stored in QSEVAL and for the KPSS form the INVESTIGATOR provides the evaluation. 4. Terminology: a. QSCAT, QSTESTCD and QSTEST are approved CDISC controlled terminology. b. Additional standardization of the QSORRES, QSSTRESC and QSSTRESN fields can be found in Section 4: Mapping Strategy. 3.2 Example for Karnofsky Performance Status Scale Domain Model The KPSS example below shows the terminology for QSCAT, QSTEST, QSTESTCD and QSORRES that should be utilized for this scale. Values for QSORRES are for prospective data collection. Sponsors mapping legacy data should retain legacy values for QSORRES. A full list of value sets for QSORRES, QSSTRESC and QSSTRESN fields is provided in Section 4: Mapping Strategy Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 3

4 Example 1: KARNOFSKY PERFORMANCE STATUS SCALE (KPSS) This example shows data from one subject collected at three visits for a KPSS questionnaire. The example uses standard controlled terminology for QSTESTCD, QSTEST, QSCAT and QSORRES for the KPSS measure. Rows 1-3: Represent the question from the KPSS Form for three visits for SUBJID= 2324-P0001. All original results are represented with the standard terminology in QSORRES. This result is then transformed into a Standard Numeric score in QSSTRESN. QS.XPT Row STUDYID DOMAIN USUBJID QSSEQ QSTESTCD QSTEST QSCAT QSORRES QSSTRESC QSSTRESN QSSTRESU KPSS-Karnofsky KPS 1 STUDYX QS 1 KPSS01 P0001 Performance Status Scale Disabled; requires special care and assistance % KPSS-Karnofsky KPS Requires considerable assistance and frequent 2 STUDYX QS 2 KPSS01 P0001 Performance Status Scale medical care % KPSS-Karnofsky KPS Requires occasional assistance, but is able to care 3 STUDYX QS 3 KPSS01 P0001 Performance Status Scale for most of his personal needs % Row QSEVAL VISITNUM QSDTC 1 (cont) INVESTIGATOR (cont) INVESTIGATOR (cont) INVESTIGATOR The data range text and numeric values for data collection needs to be populated in SUPPQS as follows. The standard terminology for QNAM and QLABEL are listed below. SUPPQS.XPT STUDYID RDOMAIN USUBJID IDVAR IDVARVAL QNAM QLABEL QVAL QORIG QEVAL STUDY01 QS 2324-P0001 QSSEQ 1 RNGTXTLO Range Text Lo Dead CRF STUDY01 QS 2324-P0001 QSSEQ 1 RNGTXTHI Range Text Hi Normal no complaints; no evidence of disease. CRF STUDY01 QS 2324-P0001 QSSEQ 1 RNGVALLO Range Value Lo 0 CRF STUDY01 QS 2324-P0001 QSSEQ 1 RNGVALHI Range Value HI 100 CRF STUDY01 QS 2324-P0001 QSSEQ 2 RNGTXTLO Range Text Lo Dead CRF STUDY01 QS 2324-P0001 QSSEQ 2 RNGTXTHI Range Text Hi Normal no complaints; no evidence of disease. CRF STUDY01 QS 2324-P0001 QSSEQ 2 RNGVALLO Range Value Lo 0 CRF STUDY01 QS 2324-P0001 QSSEQ 2 RNGVALHI Range Value HI 100 CRF STUDY01 QS 2324-P0001 QSSEQ 3 RNGTXTLO Range Text Lo Dead CRF STUDY01 QS 2324-P0001 QSSEQ 3 RNGTXTHI Range Text Hi Normal no complaints; no evidence of disease. CRF STUDY01 QS 2324-P0001 QSSEQ 3 RNGVALLO Range Value Lo 0 CRF STUDY01 QS 2324-P0001 QSSEQ 3 RNGVALHI Range Value HI 100 CRF 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 4

5 4 SDTM Mapping Strategy KPSS specific mapping strategy: This section is used for reference with the annotated CRF for further details on the CRF data capture and to understand the alignment of the questionnaire to the SDTM QS domain. It also provides guidance on how the result variables (QSORRES, QSORRESU, QSSTRESC, QSSTRESN, and QSSTRESU) should be populated for each questionnaire. If a result variable is not included in the table for a questionnaire, it should not be populated. QSTESTCD= KPSS01 QSTEST= KPSS-Karnofsky Performance Status QSORRES QSSTRESC QSSTRESN QSSTRESU Normal no complaints; no evidence of disease % Able to carry on normal activity; minor signs or symptoms of disease % Normal activity with effort; some signs or symptoms of disease % Cares for self; unable to carry on normal activity or to do active work % Requires occasional assistance, but is able to care for most of his personal needs % Requires considerable assistance and frequent medical care % Disabled; requires special care and assistance % Severely disabled; hospital admission is indicated although death not imminent % Very sick; hospital admission necessary; active supportive treatment necessary % Moribund; fatal processes progressing rapidly % Dead 0 0 % 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 5

6 SUPPLEMENTAL QUALIFIERS NAME CODES The following table contains an additional standard name codes for use in the Supplemental Qualifiers for Questionnaires (SUPPQS) special-purpose datasets. QNAM QLABEL Applicable Domains RNGTXTLO Range Text Lo QS RNGTXTHI Range Text Hi QS RNGVALLO Range Value Lo QS RNGVALHI Range Value HI QS End of Document 2012 Clinical Data Interchange Standards Consortium, Inc. All rights reserved Page 6

Alcohol Use Disorder Identification Test Self-Report Version (AUDIT-SR)

Alcohol Use Disorder Identification Test Self-Report Version (AUDIT-SR) Alcohol Use Disorder Identification Test Self-Report Version (AUDIT-SR) Questionnaire Supplement to the Study Data Tabulation Model Implementation Guide for Human Clinical Trials Prepared by TBI Standards

More information

PharmaSUG2015 - Paper DS15

PharmaSUG2015 - Paper DS15 PharmaSUG2015 - Paper DS15 Considerations in Submitting Non-Standard Variables: Supplemental Qualifiers, Findings About, or a Custom Findings Domain Jerry Salyers, Accenture Accelerated R&D Services, Berwyn,

More information

The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions

The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions Paper RS10 The CDISC Study Data Tabulation Model (SDTM): History, Perspective, and Basics Fred Wood Principal Consultant, Octagon Research Solutions ABSTRACT The CDISC (Clinical Data Interchange Standards

More information

SDTM AND ADaM: HANDS-ON SOLUTIONS

SDTM AND ADaM: HANDS-ON SOLUTIONS SDTM AND ADaM: HANDS-ON SOLUTIONS CDISC French Speaking User Group Paris, France 17 February 2012 Joris De Bondt, Head Data Standards & Process Improvements Tineke Callant, Senior Biostatistical Analyst

More information

PhUSE 2010. Paper CD13

PhUSE 2010. Paper CD13 Paper CD13 Clinical Data Interchange Standards Consortium (CDISC) integration into the Oracle Clinical/Remote Data Capture (OC/RDC) clinical data management system Peter Van Reusel, Business & Decision

More information

SDTM Validation: Methodologies and Tools

SDTM Validation: Methodologies and Tools SDTM Validation: Methodologies and Tools Bay Area CDISC Implementation Network Meeting Friday, April 30 th, 2010 Dan Shiu Disclaimer The ideas and examples presented here do NOT imply: They have been or

More information

CDISC standards and data management The essential elements for Advanced Review with Electronic Data

CDISC standards and data management The essential elements for Advanced Review with Electronic Data Session 6: Toward Electronic Submission of Study Data for New Drug Applications CDISC standards and data management The essential elements for Advanced Review with Electronic Data Yuki Ando Senior Scientist

More information

New features in SDTM-ETL v.1.2 1 SDTM-ETL TM. New Features in version 1.2

New features in SDTM-ETL v.1.2 1 SDTM-ETL TM. New Features in version 1.2 New features in SDTM-ETL v.1.2 1 SDTM-ETL TM New Features in version 1.2 This document describes the new features in version 1.2 of the SDTM-ETL TM software. It can be used in addition to the STDM-ETL

More information

Vasanth Kumar Kunitala et al, SPJTS.1.(2),187-200 ISSN 2321-4597

Vasanth Kumar Kunitala et al, SPJTS.1.(2),187-200 ISSN 2321-4597 BASIC USAGE OF CDISC SDTM GUIDANCE RULES TO STANDARDIZED DATASETSWITH SDTM DOMAINS VARIABLES AND VALUESAS PER FDA Vasanth Kumar Kunitala 1,Varun Kumar Sharma 2, Ikanshu Karla 3, Pradeep Moondra 4, Himansu

More information

CDISC Asthma Therapeutic Area Data Standards User Guide Yes, it is interesting! Paul Terrill

CDISC Asthma Therapeutic Area Data Standards User Guide Yes, it is interesting! Paul Terrill CDISC Asthma Therapeutic Area Data Standards User Guide Yes, it is interesting! Paul Terrill Rather dry no statistics here Standards matter Must have been a lot of hard work! 2 What I am not going to talk

More information

ABSTRACT On October 1st, 2008, CDASH released the first 16 common CRF streams (or domains) for use by the Pharmaceutical Industry.

ABSTRACT On October 1st, 2008, CDASH released the first 16 common CRF streams (or domains) for use by the Pharmaceutical Industry. Paper RS03-2008 A Practical Introduction to Clinical Data Acquisition Standards Harmonization (CDASH) Jennifer Price, Phoenix Data Systems, Inc, King of Prussia, PA ABSTRACT On October 1st, 2008, CDASH

More information

Note: See 7.7 Representations and Warranties, Limitations of Liability, and Disclaimer.

Note: See 7.7 Representations and Warranties, Limitations of Liability, and Disclaimer. Clinical Data Acquisition Standards Harmonization (CDASH) Prepared by: CDISC and Domain Teams CDASH_STD-1.0 01/OCT/2008 CDASH V1.0 STANDARD Revision History Document Number Release Date Updates CDASH_STD-1.0

More information

Analysis Data Model (ADaM)

Analysis Data Model (ADaM) Analysis Data Model (ADaM) Prepared by the CDISC Analysis Data Model Team Notes to Readers This is Version 2.1 of the Analysis Data Model (ADaM) Document. It includes modifications so that it corresponds

More information

Metadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide

Metadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide Metadata Submission Guidelines Appendix to the Study Data Tabulation Model Implementation Guide Prepared by the CDISC SDS Metadata Team Notes to Readers This is Version 0.9 of the Metadata Submissions

More information

USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE

USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE USE CDISC SDTM AS A DATA MIDDLE-TIER TO STREAMLINE YOUR SAS INFRASTRUCTURE Kalyani Chilukuri, Clinovo, Sunnyvale CA WUSS 2011 Annual Conference October 2011 TABLE OF CONTENTS 1. ABSTRACT... 3 2. INTRODUCTION...

More information

PharmaSUG2010 HW06. Insights into ADaM. Matthew Becker, PharmaNet, Cary, NC, United States

PharmaSUG2010 HW06. Insights into ADaM. Matthew Becker, PharmaNet, Cary, NC, United States PharmaSUG2010 HW06 Insights into ADaM Matthew Becker, PharmaNet, Cary, NC, United States ABSTRACT ADaM (Analysis Dataset Model) is meant to describe the data attributes such as structure, content, and

More information

Therapeutic Area Data Standards User Guide for Multiple Sclerosis Version 1.0

Therapeutic Area Data Standards User Guide for Multiple Sclerosis Version 1.0 Therapeutic Area Data Standards User Guide for Multiple Sclerosis Version 1.0 Prepared by the Multiple Sclerosis Outcome Assessments Consortium and the CFAST Multiple Sclerosis Development Team Notes to

More information

Business & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies

Business & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies Business & Decision Life Sciences CDISC Workshop: From SDTM to ADaM: Mapping Methodologies Jessica Minkue Mi Edou / 18th September 2014 From SDTM to ADaM: Mapping Methodologies CDISC and ADaM Introduc0on

More information

Einführung in die CDISC Standards CDISC Standards around the World. Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14.

Einführung in die CDISC Standards CDISC Standards around the World. Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14. Einführung in die CDISC Standards CDISC Standards around the World Bron Kisler (CDISC) & Andrea Rauch DVMD Tagung 11.-14. März 2015 1 Outline Overview of CDISC Therapeutic Area Standards SHARE Metadata

More information

ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA

ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA ABSTRACT: ADaM Implications from the CDER Data Standards Common Issues and SDTM Amendment 1 Documents Sandra Minjoe, Octagon Research Solutions, Wayne, PA Over the past few years, the United States Food

More information

Client Summary Palliative Care

Client Summary Palliative Care Client Summary Palliative Care DRAFT 2, March 2014 Gippsland Region Palliative Care Consortium Clinical Practice Group Policy No. Title Keywords Ratified GRPCC Client Summary Palliative Care After-hours,

More information

Data Conversion to SDTM: What Sponsors Can Do to Facilitate the Process

Data Conversion to SDTM: What Sponsors Can Do to Facilitate the Process Data Conversion to SDTM: What Sponsors Can Do to Facilitate the Process Fred Wood VP, Data Standards Consulting Octagon Research Solutions CDISC U.S. Interchange Baltimore, MD November 2009 1 Outline Background

More information

Implementing CDASH Standards Into Data Collection and Database Design. Robert Stemplinger ICON Clinical Research

Implementing CDASH Standards Into Data Collection and Database Design. Robert Stemplinger ICON Clinical Research Implementing CDASH Standards Into Data Collection and Database Design Robert Stemplinger ICON Clinical Research 1 Agenda Reasons for Using CDASH Project Outline Implementation Discussion of Results Reasons

More information

Strategies and Practical Considerations for Creating CDISC SDTM Domain Data Sets from Existing CDM Data Sets

Strategies and Practical Considerations for Creating CDISC SDTM Domain Data Sets from Existing CDM Data Sets Paper FC05 Strategies and Practical Considerations for Creating CDISC SDTM Domain Data Sets from Existing CDM Data Sets Robert W. Graebner, Quintiles, Inc., Overland Park, KS ABSTRACT Creating CDISC SDTM

More information

Introduction to the CDISC Standards

Introduction to the CDISC Standards Introduction to the CDISC Standards Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Clinical Data Interchange Standards Consortium (CDISC) encompasses a suite of standards across

More information

Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA)

Overview of CDISC Implementation at PMDA. Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) Overview of CDISC Implementation at PMDA Yuki Ando Senior Scientist for Biostatistics Pharmaceuticals and Medical Devices Agency (PMDA) CDISC 2012 Outline Introduction Update of PMDA activity CDISC implementation

More information

Data Standards Panel Discussion November 30, 2011

Data Standards Panel Discussion November 30, 2011 Data Standards Panel Discussion November 30, 2011 1 Data Standards Panel Discussion Panel Members Chuck Cooper, MD, CDER, FDA Margaret Haber, National Cancer Institute, NIH Dana Pinchotti, American College

More information

The ADaM Solutions to Non-endpoints Analyses

The ADaM Solutions to Non-endpoints Analyses The ADaM Solutions to Non-endpoints Analyses ABSTRACT Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA There always exist some analyses for non endpoints in the study. These

More information

Business & Decision Life Sciences What s new in ADaM

Business & Decision Life Sciences What s new in ADaM Business & Decision Life Sciences What s new in ADaM Gavin Winpenny 23 rd June 2015 Agenda What s happening CDISC and Regulatory Submission Landscape ADaM Implementation Guide ADaM Data Structures for

More information

A Brief Introduc/on to CDISC SDTM and Data Mapping

A Brief Introduc/on to CDISC SDTM and Data Mapping A Brief Introduc/on to CDISC SDTM and Data Mapping Agenda Flow of Clinical Trials Data The Problem Introducing CDISC Understanding SDTM Concepts of Data Mapping References 5/3/10 2 Flow of Clinical Trials

More information

PharmaSUG 2016 Paper IB10

PharmaSUG 2016 Paper IB10 ABSTRACT PharmaSUG 2016 Paper IB10 Moving from Data Collection to Data Visualization and Analytics: Leveraging CDISC SDTM Standards to Support Data Marts Steve Kirby, JD, MS, Chiltern, King of Prussia,

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #218 (NQF 0423): Functional Deficit: Change in Risk-Adjusted Functional Status for Patients with Hip Impairments National Quality Strategy Domain: Communication and Care Coordination 2016 PQRS

More information

STUDY DATA TECHNICAL CONFORMANCE GUIDE

STUDY DATA TECHNICAL CONFORMANCE GUIDE STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions

More information

Lessons on the Metadata Approach. Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014

Lessons on the Metadata Approach. Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014 1 Lessons on the Metadata Approach Dave Iberson- Hurst 9 th April 2014 CDISC Euro Interchange 2014 2 Experience Human beings, who are almost unique in having the ability to learn from the experience of

More information

Implementation of SDTM in a pharma company with complete outsourcing strategy. Annamaria Muraro Helsinn Healthcare Lugano, Switzerland

Implementation of SDTM in a pharma company with complete outsourcing strategy. Annamaria Muraro Helsinn Healthcare Lugano, Switzerland Italian-Speaking CDISC User Group 2008 Implementation of SDTM in a pharma company with complete outsourcing strategy Annamaria Muraro Helsinn Healthcare Lugano, Switzerland Background Full outsourcing

More information

Data Standards and the National Cardiovascular Research Infrastructure (NCRI)

Data Standards and the National Cardiovascular Research Infrastructure (NCRI) Data Standards and the National Cardiovascular Research Infrastructure (NCRI) A partnership with Duke Clinical Research Institute (DCRI) and the American College of Cardiology Foundation (ACCF) November

More information

Guideline for Estimating Length of Survival in Palliative Patients

Guideline for Estimating Length of Survival in Palliative Patients Guideline for Estimating Length of Survival in Palliative Patients Cornelius Woelk MD, CCFP Medical Director of Palliative Care Regional Health Authority - Central Manitoba 385 Main Street Winkler, Manitoba,

More information

Optimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools

Optimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools Optimizing Safety Surveillance During Clinical Trials Using Data Visualization Tools Laura McKain, M.D., Medical Director, Pharmacovigilance; Tammy Jackson, Director, Preclarus Development, Clinical Innovation;

More information

STUDY DATA TECHNICAL CONFORMANCE GUIDE

STUDY DATA TECHNICAL CONFORMANCE GUIDE STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions

More information

STUDY DATA TECHNICAL CONFORMANCE GUIDE

STUDY DATA TECHNICAL CONFORMANCE GUIDE STUDY DATA TECHNICAL CONFORMANCE GUIDE Technical Specifications Document This Document is incorporated by reference into the following Guidance Document(s): Guidance for Industry Providing Regulatory Submissions

More information

Copyright 2012, SAS Institute Inc. All rights reserved. VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS

Copyright 2012, SAS Institute Inc. All rights reserved. VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS VISUALIZATION OF STANDARD TLFS FOR CLINICAL TRIAL DATA ANALYSIS WENJUN BAO AND JASON CHEN JMP, SAS INC. PHUSE, SHANGHAI, NOV 28, 2014 OUTLINES: CDISC Standard SDTM ADaM Interactive Standardized TLFs Tables

More information

Implementing the CDISC standards into an existing CDMS

Implementing the CDISC standards into an existing CDMS Implementing the CDISC standards into an existing CDMS Presented by Ueng-Cheng Yang (yang@ym.edu.tw) Institute of Biomedical Informatics National Yang-Ming University 1 TCT is a resource center to support

More information

Extracting the value of Standards: The Role of CDISC in a Pharmaceutical Research Strategy. Frank W. Rockhold, PhD* and Simon Bishop**

Extracting the value of Standards: The Role of CDISC in a Pharmaceutical Research Strategy. Frank W. Rockhold, PhD* and Simon Bishop** Extracting the value of Standards: The Role of CDISC in a Pharmaceutical Research Strategy Frank W. Rockhold, PhD* and Simon Bishop** GlaxoSmithKline Research and Development. RTP NC and Stevenage, UK

More information

Karnofsky/Lansky Performance Status

Karnofsky/Lansky Performance Status Karnofsky/Lansky Performance Status The CIBMTR uses Karnofsky/Lansky performance status to determine the functional status of a recipient. Recipient performance status is a critical data field that has

More information

Therapeutic Area Standards (TAS) Initiative Project Plan

Therapeutic Area Standards (TAS) Initiative Project Plan Therapeutic Area Standards (TAS) Initiative Project Plan Version: 2.0 Document Date: June, 2014 REVISION HISTORY Version Number Revision Date Description of Change 1.0 September, 2013 Initial Document

More information

Common Misunderstandings about ADaM Implementation

Common Misunderstandings about ADaM Implementation PharmaSUG 2012 - Paper DS16 Common Misunderstandings about ADaM Implementation Nate Freimark, Theorem Clinical Research, King of Prussia, PA Susan Kenny, Amgen Inc, Thousand Oaks, CA Jack Shostak, Duke

More information

Technical Leadership Committee

Technical Leadership Committee CDISC Technical Leadership Committee Team Updates CDISC Interchange, November 2009 Baltimore Strength through collaboration. As a catalyst t for productive collaboration, CDISC brings together th individuals

More information

Analysis Data Model: Version 2.0

Analysis Data Model: Version 2.0 1 2 Analysis Data Model: Version 2.0 Prepared by the CDISC Analysis Dataset Modeling Team (ADaM) Notes to Readers This Model incorporates aspects of the previous General Considerations document version

More information

Use of standards: can we really be analysis ready?

Use of standards: can we really be analysis ready? Standards in analysis & reporting Use of standards: can we really be analysis ready? Analysis ready? Why? Reducing time to market/approval Reducing time to delivery Reducing re work Designing subsequent

More information

CDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co

CDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co CDISC Roadmap Outline: Further development and convergence of SDTM, ODM & Co CDISC Ausblick: Weitere Entwicklung und Konvergenz der CDISC-Standards SDTM, ODM & Co. Jozef Aerts - XML4Pharma Disclaimer Views

More information

BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA

BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA BRIDGing CDASH to SAS: How Harmonizing Clinical Trial and Healthcare Standards May Impact SAS Users Clinton W. Brownley, Cupertino, CA ABSTRACT The Clinical Data Interchange Standards Consortium (CDISC),

More information

CDER/CBER s Top 7 CDISC Standards Issues

CDER/CBER s Top 7 CDISC Standards Issues CDER/CBER s Top 7 CDISC Standards Issues Dhananjay Chhatre, MS, RAC edata Management Solutions Team Office of Business Informatics CDER, U.S. FDA Amy Malla Review Management CBER, U.S. FDA Background ~

More information

Practical application of SAS Clinical Data Integration Server for conversion to SDTM data

Practical application of SAS Clinical Data Integration Server for conversion to SDTM data Paper DM03 Practical application of SAS Clinical Data Integration Server for conversion to SDTM data Peter Van Reusel, Business & Decision Life Sciences, Brussels, Belgium Mark Lambrecht, SAS, Tervuren,

More information

Programme Guide PGDCDM

Programme Guide PGDCDM Post Graduate Diploma in Clinical Data Management and Biostatistics with SAS Programme Guide PGDCDM School of Health Sciences Indira Gandhi National Open University WHY THIS PROGRAMME? The Post Graduate

More information

IT Coordination Group and ECRIN Data Centers

IT Coordination Group and ECRIN Data Centers IT Coordination Group and ECRIN Data Centers Venizeleas D, Ohmann Ch April 16, 2007 DRAFT Version April 16, 2007 1 Contents Contents 2 1 Introduction 3 2 IT Platform 3 3 Platform Organization 4 3.1 IT

More information

Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management

Electronic Submission of Regulatory Information, and Creating an Electronic Platform for Enhanced Information Management Written Notice of Participation by the Clinical Data Interchange Standards Consortium (CDISC) and Written Statement for Discussion Topics to be Addressed In the FDA Public Hearing: Electronic Submission

More information

Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program

Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program Training/Internship Brochure Advanced Clinical SAS Programming Full Time 6 months Program Domain Clinical Data Sciences Private Limited 8-2-611/1/2, Road No 11, Banjara Hills, Hyderabad Andhra Pradesh

More information

Analysis Data Model (ADaM) Implementation Guide

Analysis Data Model (ADaM) Implementation Guide Analysis Data Model (ADaM) Implementation Guide Prepared by the CDISC Analysis Data Model Team Notes to Readers This Implementation Guide is Version 1.0 (V1.0) and corresponds to Version 2.1 of the CDISC

More information

Robust tools to Create Define.xml v2.0 based submission components for SDTM, ADAM & SEND Vineet Jain, Independent Consultant

Robust tools to Create Define.xml v2.0 based submission components for SDTM, ADAM & SEND Vineet Jain, Independent Consultant Robust tools to Create Define.xml v2.0 based submission components for SDTM, ADAM & SEND Vineet Jain, Independent Consultant In 2013 CDISC came out with define XML specification version 2.0. Unlike previous

More information

Medicare Part D Hospice Care Hospice Information for Medicare Part D Plans

Medicare Part D Hospice Care Hospice Information for Medicare Part D Plans P. O. Box 31397 Tampa, FL 33631 Medicare Part D Hospice Care Hospice Information for Medicare Part D Plans Table of Contents Introduction...2 Background...2 Purpose...2 1) To document that a drug is unrelated

More information

Clinical Trial Data Integration: The Strategy, Benefits, and Logistics of Integrating Across a Compound

Clinical Trial Data Integration: The Strategy, Benefits, and Logistics of Integrating Across a Compound PharmaSUG 2014 - Paper AD21 Clinical Trial Data Integration: The Strategy, Benefits, and Logistics of Integrating Across a Compound ABSTRACT Natalie Reynolds, Eli Lilly and Company, Indianapolis, IN Keith

More information

PharmaSUG2010 - Paper HS01. CDASH Standards for Medical Device Trials: CRF Analysis. Parag Shiralkar eclinical Solutions, a Division of Eliassen Group

PharmaSUG2010 - Paper HS01. CDASH Standards for Medical Device Trials: CRF Analysis. Parag Shiralkar eclinical Solutions, a Division of Eliassen Group PharmaSUG2010 - Paper HS01 CDASH Standards for Medical Device Trials: CRF Analysis Parag Shiralkar eclinical Solutions, a Division of Eliassen Group Jennie Tedrow Boston Scientific Kit Howard Kestrel Consultants

More information

PK IN DRUG DEVELOPMENT. CDISC management of PK data. Matteo Rossini Milan, 9 February 2010

PK IN DRUG DEVELOPMENT. CDISC management of PK data. Matteo Rossini Milan, 9 February 2010 Matteo Rossini Milan, 9 February 2010 Introduction to CDISC CDISC: Clinical Data Interchange Standards Consortium CDISC is a global, open, multidisciplinary, non-profit organization that has established

More information

Development of an open metadata schema for Prospective Clinical Research (openpcr)

Development of an open metadata schema for Prospective Clinical Research (openpcr) Supplementary Web Material Development of an open metadata schema for Prospective Clinical Research (openpcr) in China A. Methods We used Singapore Framework for Dublin Core Application Profiles (DCAP),

More information

Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission

Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission , October 24-26, 2012, San Francisco, USA Bridging Statistical Analysis Plan and ADaM Datasets and Metadata for Submission Abstract In this article, the relationship between the Statistical Analysis Plan

More information

Metadata and ADaM. www.cytel.com

Metadata and ADaM. www.cytel.com Metadata and ADaM 1 Disclaimer Any views or opinions presented in this presentation are solely those of the author and do not necessarily represent those of the company. 2 Agenda Introduction of ADaM Metadata

More information

Using SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA

Using SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA Using SAS Data Integration Studio to Convert Clinical Trials Data to the CDISC SDTM Standard Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT A new industry standard for clinical trials data,

More information

A white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA

A white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA THE CLINICAL DATA AND REGULATORY EXPERTS SDTM, Plus or Minus A white paper presented by: Barry Cohen Director, Clinical Data Strategies Octagon Research Solutions, Inc. Wayne, PA This Whitepaper is for

More information

SAS CLINICAL TRAINING

SAS CLINICAL TRAINING SAS CLINICAL TRAINING Presented By 3S Business Corporation Inc www.3sbc.com Call us at : 281-823-9222 Mail us at : info@3sbc.com Table of Contents S.No TOPICS 1 Introduction to Clinical Trials 2 Introduction

More information

Did you know? Accenture can deliver business outcome-focused results for your life sciences research & development organization like these:

Did you know? Accenture can deliver business outcome-focused results for your life sciences research & development organization like these: How can Accenture Accelerated R&D BPO Services help you achieve greater business value? Did you know? Accenture can deliver business outcome-focused results for your life sciences research & development

More information

Meta-programming in SAS Clinical Data Integration

Meta-programming in SAS Clinical Data Integration Meta-programming in SAS Clinical Data Integration : a programmer s perspective Mark Lambrecht, PhD Phuse Single Day Event Brussels, February 23 rd 2010. Contents SAS Clinical Data Integration : an introduction

More information

ADaM Supplement to the TAUG-Diabetes Version 1.0 (Draft)

ADaM Supplement to the TAUG-Diabetes Version 1.0 (Draft) ADaM Supplement to the TAUG-Diabetes Version 1.0 (Draft) Prepared by the CFAST Diabetes ADaM Sub-Team Notes to Readers This is the draft version 1.0 of the CDISC ADaM Supplement to the TAUG-Diabetes. It

More information

CDISC SDTM/ADaM Pilot Project 1 Project Report

CDISC SDTM/ADaM Pilot Project 1 Project Report Executive Summary Background CDISC SDTM/ADaM Pilot Project 1 Project Report CDISC is a non-profit, multidisciplinary consensus based standards development organization founded over a decade ago that has

More information

CDISC Data Standards Can Facilitate Composition of Adverse Event Narratives

CDISC Data Standards Can Facilitate Composition of Adverse Event Narratives CDISC Data Standards Can Facilitate Composition of Adverse Event Narratives Anisa Scott, Ph.D. and Richard C. Zink, Ph.D. JMP Life Sciences SAS Institute, Inc. anisa.scott@jmp.com Copyright 2010 SAS Institute

More information

How to build ADaM from SDTM: A real case study

How to build ADaM from SDTM: A real case study PharmaSUG2010 - Paper CD06 How to build ADaM from SDTM: A real case study JIAN HUA (DANIEL) HUANG, FOREST LABORATORIES, NJ ABSTRACT: Building analysis data based on the ADaM model is highly recommended

More information

Clinical Data Acquisition Standards Harmonization: Basic Data Collection Fields for Case Report Forms

Clinical Data Acquisition Standards Harmonization: Basic Data Collection Fields for Case Report Forms Clinical Data Acquisition Standards Harmonization: Basic Data Collection Fields for Case Report Forms Prepared by the CDISC CDASH Team Notice to Reviewers This is the CDASH draft posted for public comment.

More information

Current Status and Future Perspectives for Systemization of Clinical Study related the issues of CDISC in USA and other

Current Status and Future Perspectives for Systemization of Clinical Study related the issues of CDISC in USA and other Current Status and Future Perspectives for Systemization of Clinical Study related the issues of CDISC in USA and other ABSTRACT The term "the CDISC standard" has been used incorrectly for a few years.

More information

Understanding CDISC Basics

Understanding CDISC Basics Trends in Bio/Pharmaceutical Industry Understanding CDISC Basics Jane Ma Abstract Data standards can make data and its associated program more portable. The CDISC (Clinical Data Interchange Standards Consortium)

More information

ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC

ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC Paper CD01 ADaM or SDTM? A Comparison of Pooling Strategies for Integrated Analyses in the Age of CDISC Joerg Guettner, Bayer Pharma AG, Wuppertal, Germany Alexandru Cuza, UCB Biosciences GmbH, Monheim,

More information

Restorative Care. Policy, Procedures and Training Package

Restorative Care. Policy, Procedures and Training Package Restorative Care Policy, Procedures and Training Package Release Date: December 17, 2010 Disclaimer The Ontario Association of Non-Profit Homes and Services for Seniors (OANHSS) Long-Term Care Homes Act

More information

Streamlining the Flow of Clinical Trial Data: EHR to EDC to Sponsor

Streamlining the Flow of Clinical Trial Data: EHR to EDC to Sponsor Streamlining the Flow of Clinical Trial : EHR to EDC to Sponsor Landen Bain Liaison to Healthcare CDISC Interchange Standards Consortium) Jane Griffin, RPh Director, Pharmaceutical Research Cerner Corporation

More information

Rationale and vision for E2E data standards: the need for a MDR

Rationale and vision for E2E data standards: the need for a MDR E2E data standards, the need for a new generation of metadata repositories Isabelle de Zegher, PAREXEL Informatics, Belgium Alan Cantrell, PAREXEL, United Kingdom Julie James, PAREXEL Informatics, United

More information

Accenture Accelerated R&D Services: CDISC Conversion Service Overview

Accenture Accelerated R&D Services: CDISC Conversion Service Overview Accenture Life Sciences Rethink Reshape Restructure for better patient outcomes Accenture Accelerated R&D Services: CDISC Conversion Service Overview Using standards to drive speed to market and meet regulatory

More information

Development of CDISC Tuberculosis Data Standards

Development of CDISC Tuberculosis Data Standards Development of CDISC Tuberculosis Data Standards Michael Fiola Senior Director / Quintiles The presenters have disclosed that they have no proprietary or financial interests in the topics covered in this

More information

Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners

Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Managing and Integrating Clinical Trial Data: A Challenge for Pharma and their CRO Partners Within the Pharmaceutical Industry, nothing is more fundamental to business success than bringing drugs and medical

More information

Business & Decision Life Sciences

Business & Decision Life Sciences Business & Decision Life Sciences Define-it: Demo webinar Anne-Sophie Bekx / 20th May 2014 INSERT COMPANY LOGO IN MASTER SLIDE HERE History of Define.xml Define-it Software Demo Define-it versions Q &

More information

UTILIZING CDISC STANDARDS TO DRIVE EFFICIENCIES WITH OPENCLINICA Mark Wheeldon CEO, Formedix Boston June 21, 2013

UTILIZING CDISC STANDARDS TO DRIVE EFFICIENCIES WITH OPENCLINICA Mark Wheeldon CEO, Formedix Boston June 21, 2013 UTILIZING CDISC STANDARDS TO DRIVE EFFICIENCIES WITH OPENCLINICA Mark Wheeldon CEO, Formedix Boston June 21, 2013 AGENDA Introduction Real World Uses : Saving Time & Money. Your Clinical Trials Automated.

More information

Pharmaceutical Applications

Pharmaceutical Applications Integrated Summary of Safety and Efficacy Programming for Studies Using Electronic Data Capture Changhong Shi, Merck & Co., Inc., Rahway, NJ Qing Xue, Merck & Co., Inc., Rahway, NJ ABSTRACT The Integrated

More information

WHITE PAPER. CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. SUCCESSFUL TRIALS THROUGH PROVEN SOLUTIONS

WHITE PAPER. CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. SUCCESSFUL TRIALS THROUGH PROVEN SOLUTIONS WHITE PAPER CONVERTING SDTM DATA TO ADaM DATA AND CREATING SUBMISSION READY SAFETY TABLES AND LISTINGS. An innovative approach to deliver statistical analysis and data in a CDISC ADaM complient manner

More information

End-to-End E-Clinical Coverage with Oracle Health Sciences InForm GTM

End-to-End E-Clinical Coverage with Oracle Health Sciences InForm GTM End-to-End E-Clinical Coverage with InForm GTM A Complete Solution for Global Clinical Trials The broad market acceptance of electronic data capture (EDC) technology, coupled with an industry moving toward

More information

A Macro to Create Data Definition Documents

A Macro to Create Data Definition Documents A Macro to Create Data Definition Documents Aileen L. Yam, sanofi-aventis Inc., Bridgewater, NJ ABSTRACT Data Definition documents are one of the requirements for NDA submissions. This paper contains a

More information

Guidance for Industry

Guidance for Industry Reprinted from FDA s website by EAS Consulting Group, LLC Guidance for Industry Providing Regulatory Submissions in Electronic Format Standardized Study Data DRAFT GUIDANCE This guidance document is being

More information

Considering De-Identification? Legacy Data. Kymberly Lee 16-Jul-2015

Considering De-Identification? Legacy Data. Kymberly Lee 16-Jul-2015 Considering De-Identification? Legacy Data Kymberly Lee 16-Jul-2015 Introduction This presentation provides an overview of Clinical data sharing, clinical data privacy, and clinical transparency. Discuss

More information

California HealthCare Foundation Education materials for patients with advanced cancer

California HealthCare Foundation Education materials for patients with advanced cancer California HealthCare Foundation Education materials for patients with advanced cancer The California HealthCare Foundation (CHCF) commissioned research to explore options around the development of patient

More information

ABSTRACT INTRODUCTION PATIENT PROFILES SESUG 2012. Paper PH-07

ABSTRACT INTRODUCTION PATIENT PROFILES SESUG 2012. Paper PH-07 Paper PH-07 Developing a Complete Picture of Patient Safety in Clinical Trials Richard C. Zink, JMP Life Sciences, SAS Institute, Cary, NC, United States Russell D. Wolfinger, JMP Life Sciences, SAS Institute,

More information

The Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data. Ravi Shankar

The Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data. Ravi Shankar The Development of the Clinical Trial Ontology to standardize dissemination of clinical trial data Ravi Shankar Open access to clinical trials data advances open science Broad open access to entire clinical

More information

Guidance for Industry

Guidance for Industry Guidance for Industry Cancer Drug and Biological Products Clinical Data in Marketing Applications U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and

More information

How to easily convert clinical data to CDISC SDTM

How to easily convert clinical data to CDISC SDTM How to easily convert clinical data to CDISC SDTM Ale Gicqueau, Clinovo, Sunnyvale, CA Miki Huang, Clinovo, Sunnyvale, CA Stephen Chan, Clinovo, Sunnyvale, CA INTRODUCTION Sponsors are receiving clinical

More information

UnitedHealthcare Insurance Company

UnitedHealthcare Insurance Company UnitedHealthcare Insurance Company 185 Asylum Street Hartford, Connecticut 06103-3408 Policyholder: Synergy Services, Inc. Policy Number: 303968 Effective Date: January 1, 2015 Premium Due Date: January

More information

Automate Data Integration Processes for Pharmaceutical Data Warehouse

Automate Data Integration Processes for Pharmaceutical Data Warehouse Paper AD01 Automate Data Integration Processes for Pharmaceutical Data Warehouse Sandy Lei, Johnson & Johnson Pharmaceutical Research and Development, L.L.C, Titusville, NJ Kwang-Shi Shu, Johnson & Johnson

More information